Trial Profile
Effects of aprepitant on cognitive functions in heavy drinkers using fMRI
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary)
- Indications Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting
- Focus Adverse reactions
- 04 Oct 2016 Status changed from recruiting to suspended.
- 15 Mar 2014 New trial record